How do I hire a fractional VP of Sales for a biotech company in 2027?

Direct Answer
You hire a fractional VP of Sales for biotech in 2027 by first confirming you need sales leadership, not just a closer. Then you evaluate candidates on domain credibility (can they talk to PhDs and procurement?), operational rigor (can they build a CRM pipeline from scratch?), and availability (are they truly fractional or overbooked?). The cost range is wide because biotech sales cycles vary enormously — a $5k/month diagnostic tool company needs different leadership than a $15k/month therapeutic platform seeking Series A.
Why Biotech Is Different from SaaS in 2027
Biotech sales leadership is not a transferable skill from general B2B SaaS. The buyers are PhDs, procurement officers, and sometimes regulatory bodies. The sales cycle involves technical validations, clinical data reviews, and compliance checks that a typical SaaS VP has never navigated. A fractional VP who has sold research antibodies or lab automation will understand the language of limit of detection, reproducibility, and FDA submission timelines. Without that fluency, your team will waste months educating them on basics.
In 2027, biotech companies increasingly sell digital biomarkers and AI-driven drug discovery platforms. These require a seller who can articulate value to both scientists and business development teams. A fractional VP must be comfortable with technical demos and white papers, not just slide decks.
Where to Find Fractional Biotech Sales Leaders
Avoid candidates who claim to "do it all" — a true fractional VP has a defined scope and capacity limits. Ask for three recent references from biotech companies at a similar stage. Verify they can speak to pipeline generation, forecast accuracy, and team coaching.
How to Evaluate a Fractional VP for Biotech
Create a scorecard with four dimensions:
- Domain credibility: Can they explain your product's mechanism of action or value proposition to a skeptical PI?
- Operational rigor: Do they use Salesforce or HubSpot with clear stages, or do they rely on spreadsheets?
- Revenue execution: Ask for a sample 90-day plan — does it include outbound sequences, partner channels, and KOL engagement?
- Cultural fit: Biotech teams are often small, mission-driven, and science-first. A fractional VP who is purely transactional will clash.
Structuring the Engagement
A fractional VP of Sales for biotech should have a written scope of work that includes:
- Days per month (10–20 is typical)
- Specific deliverables (e.g., build a pipeline of 50 qualified opportunities, hire two SDRs, implement a CRM)
- Reporting cadence (weekly pipeline reviews, monthly board updates)
- Compensation (cash only or cash + equity; equity is common at pre-revenue stages)
- Termination clause (30 days notice, no severance)
Do not offer a full-time salary to a fractional candidate — that defeats the purpose. Instead, tie a bonus to revenue milestones (e.g., $100k in closed-won deals within 6 months). This aligns incentives without creating a permanent obligation.
Common Pitfalls to Avoid
- Hiring a SaaS VP who "learns on the job" — Biotech buyers are unforgiving. One bad meeting can burn a relationship.
- Under-scoping the role — A fractional VP who works 5 days a month cannot build a sales engine. 10–15 days is the minimum for meaningful impact.
- Ignoring compliance — If your product involves HIPAA, GDPR, or FDA regulations, your fractional VP must understand compliance documentation and audit trails.
- Expecting instant revenue — Biotech sales cycles are long. A fractional VP's first 90 days should focus on pipeline building and process, not closing.
FAQ
What is the typical cost range for a fractional VP of Sales in biotech in 2027? $8,000 to $20,000 per month for 10–20 days of engagement, depending on stage, complexity, and equity. Pre-revenue companies pay toward the lower end; Series A+ with complex cycles pay more.
How many days per month should I expect? 10–20 days is standard. Fewer than 10 days is insufficient for pipeline building and team management. More than 20 days approaches full-time cost without full-time commitment.
Can a fractional VP of Sales work remotely for my biotech company? Yes, but they must be willing to travel for key customer meetings, investor presentations, and team offsites. Biotech buyers often prefer in-person demos and lab visits.
What if I need someone with specific therapeutic area expertise? Prioritize candidates with experience in your specific domain (e.g., oncology, neurology, rare disease). General biotech experience is better than none, but niche expertise accelerates credibility.
How do I know if I need a fractional VP vs. a full-time hire? If your revenue is under $5M ARR and you cannot afford a $300k+ full-time package, go fractional. If you have a team of 5+ sellers and need daily leadership, consider full-time.
What metrics should I track for a fractional VP? Pipeline value, conversion rates, average deal size, sales cycle length, and team attainment. Avoid vanity metrics like "activity counts."
Can I convert a fractional VP to full-time later? Yes, many fractional engagements lead to full-time offers. Include a conversion clause in the contract with a defined timeline and compensation adjustment.
Where can I find vetted fractional sales leaders for biotech?